Study of the Oral Treatment MTR-601 in Cervical Dystonia

Description

Study MTR-601-201 is an 8-week, randomized, placebo-controlled study to examine the safety, tolerability, and efficacy of MTR-601 in participants with cervical dystonia.

Conditions

Cervical Dystonia

Talk to us

Study Overview

On this page

Study Details

Study overview

Study MTR-601-201 is an 8-week, randomized, placebo-controlled study to examine the safety, tolerability, and efficacy of MTR-601 in participants with cervical dystonia.

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of MTR-601, a Novel Oral Treatment in Patients With Cervical Dystonia

Study of the Oral Treatment MTR-601 in Cervical Dystonia

Condition
Cervical Dystonia
Intervention / Treatment

-

Contacts and Locations

Fountain Valley

The Parkinson's and Movement Disorder Institute, Fountain Valley, California, United States, 92708

Farmington Hills

Quest Research Institute, Farmington Hills, Michigan, United States, 48334

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 75 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Motric Bio,

    Study Record Dates

    2026-08-03